Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00713973
Other study ID # upeclin/HC/FMB-Unesp-09
Secondary ID
Status Completed
Phase N/A
First received July 8, 2008
Last updated October 17, 2008
Start date June 2007
Est. completion date June 2008

Study information

Verified date July 2008
Source UPECLIN HC FM Botucatu Unesp
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Observational

Clinical Trial Summary

Background: Compare the American and Brazilian protocols for prophylaxis of deep vein thrombosis (DVT), seeking to draft a new protocol, more comprehensive and applicable. Methods: A prospective study was conducted over a year, covering 212 patients, comparing the protocols on the stratification of risk of DVT, and the type of prophylaxis indicated. A new protocol was proposed, applied and compared to previous.


Description:

Not desired


Recruitment information / eligibility

Status Completed
Enrollment 212
Est. completion date June 2008
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

Patients who underwent plastic surgery in the Hospital of the Medical School of Botucatu, in the period of one year

Exclusion Criteria:

refusal to participate in the research protocol

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Brazil University Hospital of UNESP Botucatu São Paulo

Sponsors (1)

Lead Sponsor Collaborator
UPECLIN HC FM Botucatu Unesp

Country where clinical trial is conducted

Brazil, 

See also
  Status Clinical Trial Phase
Recruiting NCT05847205 - Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis Phase 4